Medical Oncology

Uzm. Dr. Zekeriya Hannarici

Doctor and researcher Bursa Şehir Hastanesi Bursa
Stomach NeoplasmsMelanomaSkin Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Stomach Neoplasms 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Melanoma 2 publications
  • Skin Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionBursa Şehir Hastanesisaglik.gov.trFrom source
  • Area of workStomach NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications30 publicationsEurope PMC, OpenAlexFrom source
  • ORCID0000-0002-6547-0199ORCIDFrom source
  • Last synchronised7 November 2026 00:03https://bursasehir.saglik.gov.tr/TR-606727/doktorlarimiz.html#zekeriya-hannaricisaglik.gov.tr

Scientific work

Publications on Stomach Neoplasms

30 publications
Publications by year Most: 10, in 2026
  1. 2018: 1 publication
  2. 2019: 0 publications
  3. 2020: 0 publications
  4. 2021: 4 publications
  5. 2022: 3 publications
  6. 2023: 2 publications
  7. 2024: 6 publications
  8. 2025: 4 publications
  9. 2026: 10 publications

  1. Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters

    BMC cancer, 2026

    DOI 10.1186/s12885-026-15878-7 PMID 41851668 Open-access full textSource: Europe PMC

  2. Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8673435/v1 Open-access full textSource: OpenAlex

  3. Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e13021 Source: OpenAlex

  4. Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland), 2026

    DOI 10.3390/diagnostics16121759 PMID 42351419 Open-access full textSource: Europe PMC

  5. Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15124502 PMID 42355670 Open-access full textSource: Europe PMC

  6. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

    Biomedicines, 2026

    DOI 10.3390/biomedicines14030579 PMID 41898226 Open-access full textSource: Europe PMC

  7. Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s569515 PMID 41859752 Open-access full textSource: OpenAlex

  8. The impact of digital health technology use on oncology-specific clinical guideline adherence among medical oncologists in Turkiye

    Anatolian Current Medical Journal, 2026

    DOI 10.38053/acmj.1943411 Open-access full textSource: OpenAlex

  9. Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

    Journal of Medicine and Palliative Care, 2026

    DOI 10.47582/jompac.1959390 Open-access full textSource: OpenAlex

  10. APPROACH TO METASTATIC ADRENAL MASSES

    Turkiye Klinikleri eBooks, 2026

    DOI 10.5336/978-625-5439-07-9_p141 Source: OpenAlex

View all 30 publications